These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 15827781

  • 1. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    González-Moreno S, Brun E, Sugarbaker PH.
    Ann Surg Oncol; 2005 Jan; 12(1):72-80. PubMed ID: 15827781
    [Abstract] [Full Text] [Related]

  • 2. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
    Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, Chang D.
    Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
    [Abstract] [Full Text] [Related]

  • 3. Discordant histology of primary appendiceal adenocarcinoid neoplasms with peritoneal dissemination.
    Yan TD, Brun EA, Sugarbaker PH.
    Ann Surg Oncol; 2008 May; 15(5):1440-6. PubMed ID: 18299936
    [Abstract] [Full Text] [Related]

  • 4. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding.
    González-Moreno S, Sugarbaker PH.
    Br J Surg; 2004 Mar; 91(3):304-11. PubMed ID: 14991630
    [Abstract] [Full Text] [Related]

  • 5. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD, Bijelic L, Sugarbaker PH.
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma.
    Yan TD, Yoo D, Sugarbaker PH.
    Eur J Surg Oncol; 2006 Nov; 32(9):948-53. PubMed ID: 16806796
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
    Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL.
    Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix.
    Elias D, Glehen O, Pocard M, Quenet F, Goéré D, Arvieux C, Rat P, Gilly F, Association Française de Chirurgie.
    Ann Surg; 2010 May; 251(5):896-901. PubMed ID: 20395843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lymph node metastases in diffuse malignant peritoneal mesothelioma.
    Baratti D, Kusamura S, Cabras AD, Laterza B, Balestra MR, Deraco M.
    Ann Surg Oncol; 2010 Jan; 17(1):45-53. PubMed ID: 19856030
    [Abstract] [Full Text] [Related]

  • 15. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
    Bijelic L, Yan TD, Sugarbaker PH.
    J Surg Oncol; 2008 Sep 15; 98(4):295-9. PubMed ID: 18726900
    [Abstract] [Full Text] [Related]

  • 16. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.
    Ann Surg Oncol; 2008 Feb 15; 15(2):526-34. PubMed ID: 18043976
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC.
    Ross A, Sardi A, Nieroda C, Merriman B, Gushchin V.
    Eur J Surg Oncol; 2010 Aug 15; 36(8):772-6. PubMed ID: 20561764
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.